Epigenetic reprogramming in breast cancer: From new targets to new therapies

Tiffany A. Katz, Yi Huang, Nancy E. Davidson, Rachel C. Jankowitz

Research output: Contribution to journalReview article

Abstract

Breast cancer is the most commonly diagnosed cancer and the second leading cause of cancer death among women in the United States. Recently, interest has grown in the role of epigenetics in breast cancer development and progression. Epigenetic changes such as DNA methylation, histone modifications, and abnormal expression of non-coding RNAs emerged as novel biomarkers in breast cancer diagnosis, therapy, and prevention. This review focuses on the most recent mechanistic findings underlying epigenetic changes in breast cancer development and their role as predictors of breast cancer risk. The rapid progress in our understanding of epigenetic findings in breast cancer has opened new avenues for potential therapeutic approaches via identification of epigenetic targets. We highlight the development of novel epigenetically targeted drugs, relevant clinical trials in breast cancer patients, and recent approaches combining epigenetic agents with chemotherapy and/or endocrine therapy that may incrementally improve long-term outcomes in appropriately selected breast cancer patients. Biomarkers of response are needed, however, to identify patient subsets that are most likely to benefit from epigenetic treatment strategies.

Original languageEnglish (US)
Pages (from-to)397-408
Number of pages12
JournalAnnals of Medicine
Volume46
Issue number6
DOIs
StatePublished - Sep 1 2014

Keywords

  • Biomarkers
  • Breast cancer
  • Combination therapy
  • DNA methylation
  • DNA methyltransferase inhibitor
  • Epigenetic
  • Histone deacetylase inhibitor
  • Histone demethylase
  • Post-translational modification

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Epigenetic reprogramming in breast cancer: From new targets to new therapies'. Together they form a unique fingerprint.

  • Cite this